The Next Wave in AF Care: Time to Redefine and Extend Clinical Indications for LAAC?

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Cordis Corporation, a Johnson & Johnson company; GE Healthcare; Terumo Medical Corporation</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Edwards Lifesciences</li></ul>